Mechanisms of Tissue Repair After Muscle Injury and Tendon Strain
Regulation of Human Tendon and Skeletal Muscle Protein Turnover Following Tissue Injury: Mechanisms Behind Regeneration and Injury Preventive Adaptations
1 other identifier
interventional
25
1 country
1
Brief Summary
The study is a 5-week human study including 24 18-35 year old healthy men. Each participant will have muscle injury and tendon strain induced in one leg using neuromuscular electrical stimulation in conjunction with forced lengthening contractions. The investigators will monitor the recovery from injury/strain over a 4 week period, in which half of the subjects will receive growth hormone (somatropin) to stimulate the connective tissue synthesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2023
CompletedStudy Start
First participant enrolled
April 11, 2023
CompletedFirst Posted
Study publicly available on registry
April 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2024
CompletedJanuary 9, 2024
January 1, 2024
9 months
March 17, 2023
January 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Effect of somatropin on muscle protein synthesis 14 days after injury
The difference in fractional synthesis rate in muscle proteins 14 days after injury with or without 14 days treatment with somatropin. Measured using deuterated water
14 days
Secondary Outcomes (14)
Muscle protein synthesis 7 days after injury
7 days
Muscle protein synthesis 14 days after injury
14 days
Muscle protein breakdown 14 days after injury
14 days
Muscle protein breakdown 7 days after injury
7 days
Muscle protein breakdown 28 days after injury
28 days
- +9 more secondary outcomes
Study Arms (2)
Growth hormone/somatropin
EXPERIMENTALSomatropin over two weeks (33.3 ug/kg/day in the first week, 50 ug/kg/day in the second week)
Placebo
PLACEBO COMPARATORInjections of placebo/saline over two weeks
Interventions
One bout of neuromuscular electrical stimulation in conjunction with forced lengthening contractions on one leg
Eligibility Criteria
You may qualify if:
- Healthy men
- BMI between 18.5-30 kg/m\^2
You may not qualify if:
- Smoking
- Regular strength training within the last 3 months
- Current or former use of anabolic steroids or growth hormone
- Use of corticosteroids in the last 3 months
- Use of blood thinning medication
- Use of medication which can affect muscle protein synthesis
- Current or former drug og alcohol abuse
- Knee pain
- Previous participation in studies using deuterated water or alanine tracers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Medicine Copenhagen
Copenhagen, 2400, Denmark
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, postdoc
Study Record Dates
First Submitted
March 17, 2023
First Posted
April 12, 2023
Study Start
April 11, 2023
Primary Completion
January 3, 2024
Study Completion
January 3, 2024
Last Updated
January 9, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
The IPD will be made available upon individual request once the study is finalised and published.